Trial Profile

Comparative study of the effect of intranasal insulin on memory deficits in type 2 diabetes and early Alzheimer´s dementia (INSULA)

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 28 May 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Insulin aspart (Primary)
Indications Alzheimer's disease; Mild cognitive impairment; Type 2 diabetes mellitus
Focus Therapeutic Use
Acronyms INSULA

Most Recent Events

09 Mar 2016 Status changed from recruiting to discontinued, according to European Clinical Trials Database record.
23 May 2013 New source identified and integrated (European Clinical Trials Database: EudraCT2008-008555-41).
15 Nov 2012 Status changed from planning to recruiting as reported by German Clinical Trials Register record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com